NasdaqCM - Nasdaq Real Time Price USD
Renovaro Inc. (RENB)
0.3756
+0.0274
+(7.87%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ABILDGAARD OLE Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 13, 2024 | -- |
| MILLER AVRAM Director | Stock Award(Grant) | Oct 23, 2023 | 1,000,000 |
| SINDLEV RENE Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Feb 20, 2024 | -- |
| VAN TILBURG MAURICE Director | Stock Award(Grant) | Jan 21, 2025 | 250,000 |
| WEINSTEIN DAVID HERSHEL Chief Executive Officer | Stock Award(Grant) | Oct 14, 2024 | 250,000 |
| WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 29, 2024 | -- |
Related Tickers
YMAB Y-mAbs Therapeutics, Inc.
4.1200
-3.29%
CLDI Calidi Biotherapeutics, Inc.
0.4801
+2.37%
TELO Telomir Pharmaceuticals, Inc.
2.5400
-2.31%
LIPO Lipella Pharmaceuticals Inc.
2.4100
+0.63%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2302
+2.04%
PEG.CO Pharma Equity Group A/S
0.0800
-5.66%
EVAX Evaxion Biotech A/S
1.4900
+8.76%
CNTX Context Therapeutics Inc.
0.9437
+0.10%
ENTX Entera Bio Ltd.
2.0700
+6.15%
CDT Conduit Pharmaceuticals Inc.
0.5565
-4.22%